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The prevalence of HIV and AIDS among persons 50
years of age and older continues to increase as a conse-
quence both of improved antiretroviral efficacy extend-
ing survival among individuals who contracted the
disease earlier in the epidemic and continued primary
infection in older individuals. Management of older
HIV-infected patients is complicated by the presence of
comorbidities that are more common with increasing
age, such as diabetes mellitus, cancer, and cardiovascu-
lar, renal, hepatic, and bone diseases. Some of these
conditions have specific links to HIV infection or with
its treatment. Others are consequences of remaining
alive to reach an older age. While a determination of
the relative contribution of age, HIV status, and antire-
troviral exposure to these comorbidities is an important
research question, there are also important management
issues. In particular, it is important to establish if man-
agement of these co-morbidities should differ because of
the HIV status of the patient. While these research
issues are being resolved, the assessment of comorbid-
ities in older persons should become part of routine
care, and at the very least routine age-specific guidelines
should be used for screening. Management of older per-
sons with HIV should include baseline evaluation of car-
diovascular risk and regular monitoring of fasting lipid
and glucose levels, renal function, and markers of bone
disease. Furthermore, co-morbidities have an important
influence on antiretroviral selection, as avoidance of
metabolic and other toxicities or drug-drug interactions
is a key issue.
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